[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341895-105":59,"doc-detail-341895-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","efficacy-of-different-medications-in-the-treatment-of-gynaecological-tumours-a-clinical-meta-analysis","Efﬁcacy of different medications in the treatment of gynaecological tumours - a clinical meta-analysis","","Clinical evidence on medication efficacy for gynaecological tumours is limited by late-stage diagnosis, variable treatment response, recurrence risk, and inconsistent therapeutic outcomes. A clinical meta-analysis synthesized systemic reviews and studies evaluating multiple drug classes. Results indicated improved survival with metformin, higher overall and/or progression-free survival with statins (lipophilic and hydrophilic), and time-varying benefits for beta-blocker use during neoadjuvant treatment. Aspirin effects appeared significant but with minimal advantage for continuous users. Conclusions for NA-NSAIDs, metformin, beta-blockers, and aspirin were constrained by insufficient evidence, while most statin findings suggested survival benefits, though bias may influence results.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/efficacy-of-different-medications-in-the-treatment-of-gynaecological-tumours-a-clinical-meta-analysis/341895/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/efficacy-of-different-medications-in-the-treatment-of-gynaecological-tumours-a-clinical-meta-analysis/341895.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What question does the meta-analysis address?","Question",{"text":113,"@type":114},"It evaluates the efficacy of different medications used to treat gynaecological tumours by synthesizing systemic reviews and relevant articles.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which medications showed improved survival-related outcomes?",{"text":118,"@type":114},"Metformin use was associated with higher survival, and statin use showed higher overall and/or progression-free survival; lipophilic and hydrophilic statins both appeared to perform better.",{"name":120,"@type":111,"acceptedAnswer":121},"Why can firm conclusions not be drawn for some drug classes?",{"text":122,"@type":114},"The conclusion states that associations between survival and NA-NSAIDs, metformin, beta-blockers, and aspirin cannot be fully determined due to insufficient evidence, and bias across studies may affect results.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},341895,1790419611,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","TYPE Original Research PUBLISHED 09 September 2024 DOI 10.3389/fonc.2024.1428937  \nOPEN ACCESS  \nEDITED BY Hailin Tang,  \nSun Yat-sen University Cancer Center (SYSUCC), China  \nREVIEWED BY Jie Luo,  \nThe First Afﬁliated Hospital of Guangdong Pharmaceutical University, China Wenxiao Zheng,  \nUniversity of Pittsburgh, United States Xuefeng Chen,  \nNo. 1 People’s Hospital of Xiangshan, China Ujjal Bhawal,  \nNihon University, Japan  \n*CORRESPONDENCE Qiaoying Chen  \n [cqyjlh222@163.com](cqyjlh222@163.com)  \nRECEIVED 07 May 2024  \nACCEPTED 26 June 2024  \nPUBLISHED 09 September 2024  \nCITATION  \nChen Q (2024) Efﬁcacy of different medications in the treatment of gynaecological tumours:  \na clinical meta-analysis.  \nFront. Oncol. 14:1428937 .  \ndoi: 10.3389/fonc.2024.1428937  \nCOPYRIGHT  \n© 2024 Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nEfﬁcacy of different medications in the treatment of gynaecological tumours: a clinical meta-analysis  \nQiaoying Chen*  \nDepartment of Gynecology, Women ’s and Children’s Hospital of Ningbo University, Ningbo, Zhejiang, China  \nBackground: A gynaecological tumour is one of the world’s leading causes of death for women globally. Among women, cancer is the 8th most common cause of death. Since there are no such programmes, the majority of women who are diagnosed with the condition are either in advanced stages or do not respond well to current treatments. Even if patients react to the treatments, they still risk having the cancer return, at which point any further medical intervention is met with resistance.  \nMethod: For this study, we selected the systemic reviews and articles that have the use of different medications used for the treatment of gynaecological tumours.  \nResults: Regarding metformin use, this study found a positive relationship between higher survival and metformin use. Five of the studies that examined the use of statins revealed a link between statin use and higher overall and/or progression-free survival rates. Individuals on lipophilic and hydrophilic statins would do better. Research evaluating beta-blocker use during neoadjuvant treatment revealed a time-varying effect, with improved survival seen across all users early in the follow-up period. However, only non-selective beta-blocker users demonstrated a correlation with higher survival after ﬁve years. One study found that the beneﬁts of aspirin use were signiﬁcant, but the advantage for continuous users (both before and after diagnosis) was minimal.  \nConclusion: Conclusions on the association between gynaecological tumour survival and NA-NSAIDs, metformin, beta-blockers, and aspirin cannot be drawn due to insufﬁcient evidence. However, the vast majority of statin studies have demonstrated that users had higher rates of survival. Bias, however, bias may affect the results of the studies.  \nKEYWORDS  \ngynaecologic neoplasms, drug therapy, survival rate, non-steroidal anti-inﬂammatory agents (NSAIDs), metformin  \nFrontiers in Oncology 01 [frontiersin.org](frontiersin.org)  \nIntroduction  \nOne of the leading causes of death among females worldwide is the tumour of the gynaecological system (1) . Cancer-related deaths among females are the eighth leading cause. At present, no such population-based programs are screening that help in detecting these cancers early (2) . Because there are no such programs, most of the women when diagnosed with the disease in advanced stages or their response towards the treatments that exist is not well. Even if they respond to the treatments, they also face a recurrence of that cancer, which t","cbCairEuKLZRfekV","https://ap.wps.com/l/cbCairEuKLZRfekV","pdf",820100,"English","# Introduction\n## Background and rationale\n## Gynaecological cancer screening\n# Methods\n## Included reviews and studies\n# Results\n## Metformin\n## Statins\n## Beta-blockers\n## Aspirin\n# Conclusion","[{\"question\":\"What question does the meta-analysis address?\",\"answer\":\"It evaluates the efficacy of different medications used to treat gynaecological tumours by synthesizing systemic reviews and relevant articles.\"},{\"question\":\"Which medications showed improved survival-related outcomes?\",\"answer\":\"Metformin use was associated with higher survival, and statin use showed higher overall and/or progression-free survival; lipophilic and hydrophilic statins both appeared to perform better.\"},{\"question\":\"Why can firm conclusions not be drawn for some drug classes?\",\"answer\":\"The conclusion states that associations between survival and NA-NSAIDs, metformin, beta-blockers, and aspirin cannot be fully determined due to insufficient evidence, and bias across studies may affect results.\"}]","Efﬁcacy of different medications in the treatment of gynaecological tumours - a clinical meta-analysis | PDF",1790044273,23,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/934b23c888a437be4331eef929b1aa27.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/768394cd6e15395e0a36b1fa3d56e3d2.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39aa6227b27134ee249afece606c9051.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9b031152eb637e4ca7834f75d058619c.webp",980,1385]